Atlas Trials

The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer

Clinical trial NCT06483919 · UNKNOWN

Trial details

NCT number
NCT06483919
Sponsor
Jinming Yu
Status
UNKNOWN
Study type
OBSERVATIONAL
Small-cell Lung Cancer
Start date
2023-10-01
Primary completion
2025-01-30
Enrollment
228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.